Anna D. Kraus

Anna Durand Kraus currently chairs the firm’s Health Care practice and is resident in the Washington, DC office.  She regularly advises clients on Medicare reimbursement matters, particularly those arising under Medicare Part B and the Medicare Part D outpatient prescription drug benefit.  She also has extensive experience with the Medicaid Drug Rebate program. In addition, Ms. Kraus is expert in health information privacy issues, including those arising under the Health Insurance and Portability Act of 1996 (“HIPAA”).  She joined the firm after spending seven years as Deputy General Counsel to the U.S. Department of Health and Human Services.

Representative Matters

• Assisted Kos Pharmaceuticals to obtain Medicare Part D coverage for its previously excluded product.
• Assisted several pharmaceutical manufacturers in reinstating Medicaid coverage for products dropped from the program by the Centers for Medicare & Medicaid Services (CMS).
• Assisted numerous pharmaceutical manufacturers to ensure that their research activities conform to HIPAA privacy requirements (activities included preparing investigator disclosure documents, contract research organization (CRO) agreements, clinical trial agreements, service provider agreements, informed consents and authorizations).

Previous Experience

•  U.S. Department of Health and Human Services, Deputy General Counsel (1993-2001)

Publications and Speeches

• "CMS Issues Final Rule to Implement Medicaid Drug Pricing and Reimbursement Provisions of the Deficit Reduction Act," Covington E-Alert (8/7/2007), Co-Author
• "New Hampshire Prescription Data Ban Ruled Unconstitutional," Covington E-Alert (5/17/2007), Co-Author
• "CMS Issues Proposal to Revise Clinical Trial Policy National Coverage Determination," Covington E-Alert (5/3/2007), Co-Author